Ebola | ||||||
NEWS | ||||||
Pharmaceutical Entrepreneur, William J. Polvino, MD Joins SAB Biotherapeutics' Business ... SAB is developing products for several targets including seasonal influenza, mycoplasma, C-Diff, Zika and Ebola. In addition, a Phase I Clinical Trial ...
| ||||||
See more results | Edit this alert |
You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
Send Feedback |
Tidak ada komentar:
Posting Komentar